refractory follicular lymphoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Phase 3 (1)

Interventional (2)

BeiGene (1)
Epizyme, Inc. (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcarcinoma

I am/have/hadtriple-negative breast cancer

I am/have/hadsmall cell lung cancer

I am/have/hadhysterectomy

I am/have/hadrenal cell carcinoma

I am/have/hadmsi-h

I am/have/hadsolid tumors

I am/have/hadhigh-frequency microsatellite instability

I am/have/hadmeasurable disease

I am/have/hadb-cell lymphoma

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadtotal body irradiation

I am/have/hadexperimental therapy

I am/have/hadbone marrow procedure

I am/have/hadrenal function

I am/have/hadbilateral oophorectomy

I am/have/hadchemoimmunotherapy

I am/have/hadcancer, ovarian

I am/have/hadnon-small cell lung cancer

I am/have/hadurothelial carcinoma

added new label for I am/have/had

more

I am looking for

I am looking fortazemetostat

I am looking forrituximab

I am looking forhuman chorionic gonadotropin

I am looking foribritumomab tiuxetan

I am looking forhepatitis b surface antigen

I am looking forrevlimid

I am looking forbeta human chorionic gonadotropin

I am looking formonoclonal protein

I am looking fortislelizumab

I am looking fortositumomab

I am looking formonoclonal antibodies

I am looking formelanoma

I am looking fornitrosoureas

I am looking forzanubrutinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Study in Subjects With Relapsed/Refractory Follicular Lymphoma

This is a multicenter, double-blind, active-controlled, randomized, 3-stage, biomarker enrichment design featuring early futility stopping and sample-size re-estimation with safety run-in designed to evaluate the efficacy and safety of tazemetostat in combination with R2 in subjects with R/R FL, who have completed at least 1 prior systemic chemotherapy, immunotherapy, or …

tazemetostat

rituximab

human chorionic gonadotropin

revlimid

hysterectomy

0 views
16 Feb, 2024
8 locations

Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Brief Title: Study of BGB-10188 as Monotherapy and in Combination With Zanubrutinib and Tislelizumab

The purpose of this study is to determine the maximum tolerated dose (MTD), recommended Phase 2 dose(RP2D),safety & tolerability of BGB-10188: as monotherapy in participants with mature B-cell malignancies; oin combination with zanubrutinib in participants with relapse/refractory follicular lymphoma (R/R FL), mantle cell lymphoma (MCL) or diffuse large B-cell lymphoma …

carcinoma

triple-negative breast cancer

small cell lung cancer

solid tumors

msi-h

0 views
16 Feb, 2024
4 locations

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.